Skip to main content
Equibles
BTCY logo

BTCY · Biotricity Inc. · Webcasts, Transcripts & Audio

Track BTCY — free

Use BTCY with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research BTCY.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.66 At close · Aug 5
Rebalance outlook locked
Going-concern doubt — flagged Aug 19, 2026

Substantial doubt about the company's ability to continue as a going concern.

“Those conditions raise substantial doubt about its ability to continue as a going concern for a period of one year from the issuance of these condensed consolidated interim financial statements.”
View the 10-Q filed Aug 19, 2026
Market Cap
$2.59M
Shares
19.91M
Volume · Aug 5 321.5K Avg daily vol (3M) 78.21K

Biotricity Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for Biotricity Inc. (BTCY), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▲115.3% $744,585 −$2.96M '21 Q2 20-11-20 ▲162.2% $1.00M −$3.90M '21 Q3 21-02-12 ▲227.1% $1.19M −$5.47M '21 Q4 21-06-17 ▲290.4% $1.76M −$5.66M '22 Q1 21-08-17 ▲92.8% $1.93M −$7.11M '22 Q3 22-02-16 ▲81% $2.15M −$5.61M '22 Q4 22-03-31 ▲16.5% $2.06M −$4.78M '23 Q1 22-08-17 ▲31.8% $2.38M −$4.69M '23 Q2 22-11-18 ▲27.4% $2.46M −$4.52M '23 Q3 22-12-31 ▲46.9% $3.02M −$3.41M '24 Q1 23-07-05 ▲20.9% $2.97M −$2.81M '24 Q3 23-12-31 ▲13% $3.27M −$1.56M '25 Q2 24-11-20 ▲21.7% $3.62M −$1.23M '25 Q3 25-02-24 ▲16.5% $3.70M −$1.94M '25 Q4 25-03-31 ▲18.9% $3.89M −$690,913 '26 Q2 25-11-18 LATEST ▲10.2% $3.99M −$717,067 '26 Q3 26-02-18
Earnings call
FY26 · Q3
2026-02-18
Biotricity Inc. (BTCY) Q3 2026 Earnings Call
Revenue
$3.99M
▲ 10.2% YoY
Diluted EPS
$-0.04
Gross margin
81.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q2
2025-11-18
Biotricity Inc. (BTCY) Q2 2026 Earnings Call Transcript
Confident tone Biocore Pro commercial expansion Commercial growth initiatives Strategic partnerships and market access
Revenue
$3.89M
▲ 18.9% YoY
Diluted EPS
$-0.03
Gross margin
81.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2025-03-31
Biotricity Inc. (BTCY) Q4 2025 Earnings Call Transcript
Confident tone Biocore Pro flagship device adoption Revenue growth and gross margin expansion Cardiac AI cloud platform and FDA clearance
Revenue
$3.70M*
▲ 16.5% YoY
Gross margin
80.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-02-24
Biotricity Inc. (BTCY) Q3 2025 Earnings Call
Revenue
$3.62M
▲ 21.7% YoY
Diluted EPS
$-0.05
Gross margin
76.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2024-11-20
Biotricity Inc. (BTCY) Q2 2025 Earnings Call Transcript
Confident tone Largest inventory order / supply readiness Path to profitability and EBITDA breakeven Neurology and pulmonology expansion
Revenue
$3.27M
▲ 13% YoY
Diluted EPS
$-0.07
Gross margin
75.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q3
2023-12-31
Biotricity Inc. (BTCY) Q3 2024 Earnings Call Transcript
Revenue
$2.97M
▲ 20.9% YoY
Diluted EPS
$-0.34
Gross margin
72.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2023-07-05
Biotricity Inc. (BTCY) Q1 2024 Earnings Call Transcript
Revenue
$3.02M
▲ 46.9% YoY
Diluted EPS
$-0.41
Gross margin
63.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q3
2022-12-31
Biotricity Inc. (BTCY) Q3 2023 Earnings Call Transcript
Revenue
$2.46M
▲ 27.4% YoY
Diluted EPS
$-0.55
Gross margin
57.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2022-11-18
Biotricity Inc. (BTCY) Q2 2023 Earnings Call Transcript
Revenue
$2.38M
▲ 31.8% YoY
Diluted EPS
$-0.57
Gross margin
53.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2022-08-17
Biotricity Inc. (BTCY) Q1 2023 Earnings Call Transcript
Revenue
$2.06M
▲ 16.5% YoY
Diluted EPS
$-0.10
Gross margin
59.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2022-03-31
Biotricity Inc. (BTCY) Q4 2022 Earnings Call Transcript
Revenue
$2.15M*
▲ 81% YoY
Gross margin
67.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-02-16
Biotricity Inc. (BTCY) Q3 2022 Earnings Call Transcript
Revenue
$1.93M
▲ 92.8% YoY
Gross margin
42.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2021-08-17
Biotricity Inc. (BTCY) Q1 2022 Earnings Call Transcript
Revenue
$1.76M
▲ 290.4% YoY
Gross margin
66.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2021-06-17
Biotricity Inc. (BTCY) Q4 2021 Earnings Call Transcript
Revenue
$1.19M*
▲ 227.1% YoY
Gross margin
62.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-02-12
Biotricity Inc. (BTCY) Q3 2021 Earnings Call Transcript
Revenue
$1.00M
▲ 162.2% YoY
Gross margin
14.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2020-11-20
Biotricity Inc. (BTCY) Q2 2021 Earnings Call Transcript
Revenue
$744,585
▲ 115.3% YoY
Gross margin
18.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–16 of 16 webcasts
Key facts CIK 1630113 CUSIP 09074H203 Visit website Investor relations